CD22 CAR T-cell immunotherapy trial open for children and young adults whose leukemia escapes CD19 CAR T-cell … – Science Daily
|
CD22 CAR T-cell immunotherapy trial open for children and young adults whose leukemia escapes CD19 CAR T-cell …
Science Daily In PLAT-02, the CAR T cells are reprogrammed to recognize and target the CD19 protein that is expressed by most precursor B acute lymphoblastic leukemia cells. However, in some patients, the leukemia recurred without the CD19 target and expressed a … |
